Screening individuals for lung cancer with low-dose CT on a nonrisk basis is associated with a marked reduction in lung cancer mortality and better overall survival, reveals Chinese data.
New evidence from a Chinese cohort presented at the European Lung Cancer Congress (ELCC) 2026 shows that one-time low-dose ...
A UIS epidemiologist is leading a community effort to reduce lung cancer risk through radon education, free test kits and ...
Renovaro Inc. announces funding approval for LUMINA, a platform detecting minimal residual disease in lung cancer using multi-omics and AI. Renovaro Inc. announced that its subsidiary, RenovaroCube, ...
Core Director: Rui-Ming Liu, Ph.D. Idiopathic pulmonary fibrosis (IPF) is a most enigmatic fatal lung disorder. Although significant progress has been made in our understanding of IPF pathogenesis, ...
Public Health Relevance Statement: Idiopathic Pulmonary Fibrosis (IPF) is fatal lung disorder for which no U.S. FDA-approved drugs currently exist. This project will lead to the development of novel ...